Annual Operating Expenses
$19.12 M
-$8.84 M-31.62%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual total operating expenses is $19.12 million, with the most recent change of -$8.84 million (-31.62%) on April 30, 2024.
- During the last 3 years, IPA annual operating expenses has risen by +$7.11 million (+59.19%).
- IPA annual operating expenses is now -31.62% below its all-time high of $27.95 million, reached on April 30, 2023.
Performance
IPA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$4.58 M
-$516.30 K-10.13%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly total operating expenses is $4.58 million, with the most recent change of -$516.30 thousand (-10.13%) on October 31, 2024.
- Over the past year, IPA quarterly operating expenses has dropped by -$516.30 thousand (-10.13%).
- IPA quarterly operating expenses is now -51.95% below its all-time high of $9.53 million, reached on July 31, 2022.
Performance
IPA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IPA Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.6% | -10.1% |
3 y3 years | +59.2% | -10.1% |
5 y5 years | +118.7% | -10.1% |
IPA Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -31.6% | +59.2% | -52.0% | +8.1% |
5 y | 5-year | -31.6% | +118.7% | -52.0% | +150.4% |
alltime | all time | -31.6% | >+9999.0% | -52.0% | +5196.6% |
ImmunoPrecise Antibodies Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Oct 2024 | - | $4.58 M(-10.1%) |
Jul 2024 | - | $5.10 M(+4.5%) |
Apr 2024 | $19.12 M(-31.6%) | $4.88 M(+0.8%) |
Jan 2024 | - | $4.84 M(+14.2%) |
Oct 2023 | - | $4.24 M(-13.7%) |
Jul 2023 | - | $4.91 M(-1.8%) |
Apr 2023 | $27.95 M(+26.8%) | $5.00 M(-10.3%) |
Jan 2023 | - | $5.58 M(-29.9%) |
Oct 2022 | - | $7.96 M(-16.6%) |
Jul 2022 | - | $9.53 M(+59.4%) |
Apr 2022 | $22.04 M(+83.6%) | $5.98 M(+10.6%) |
Jan 2022 | - | $5.41 M(-6.1%) |
Oct 2021 | - | $5.76 M(+20.3%) |
Jul 2021 | - | $4.79 M(+14.9%) |
Apr 2021 | $12.01 M(+35.2%) | $4.17 M(+18.7%) |
Jan 2021 | - | $3.51 M(+34.6%) |
Oct 2020 | - | $2.61 M(+42.5%) |
Jul 2020 | - | $1.83 M(-19.2%) |
Apr 2020 | $8.88 M(+1.6%) | $2.26 M(+23.1%) |
Jan 2020 | - | $1.84 M(-30.0%) |
Oct 2019 | - | $2.63 M(+22.7%) |
Jul 2019 | - | $2.14 M(-28.5%) |
Apr 2019 | $8.74 M(+54.7%) | $3.00 M(+66.2%) |
Jan 2019 | - | $1.80 M(-7.4%) |
Oct 2018 | - | $1.95 M(+5.7%) |
Jul 2018 | - | $1.84 M(-11.0%) |
Apr 2018 | $5.65 M(+171.3%) | $2.07 M(+26.6%) |
Jan 2018 | - | $1.64 M(+40.1%) |
Oct 2017 | - | $1.17 M(+71.1%) |
Jul 2017 | - | $682.00 K(-42.8%) |
Apr 2017 | $2.08 M(>+9900.0%) | $1.19 M(+123.9%) |
Jan 2017 | - | $532.80 K(+4974.3%) |
Sep 2016 | - | $10.50 K(+45.8%) |
Jun 2016 | - | $7200.00(+132.3%) |
Mar 2016 | - | $3100.00(-72.3%) |
Dec 2015 | $5400.00(-83.8%) | - |
Dec 2015 | - | $11.20 K(+409.1%) |
Sep 2015 | - | $2200.00(-132.8%) |
Jun 2015 | - | -$6700.00(+204.5%) |
Mar 2015 | - | -$2200.00(-81.0%) |
Dec 2014 | $33.40 K(-61.6%) | - |
Dec 2014 | - | -$11.60 K(-143.1%) |
Sep 2014 | - | $26.90 K(+1482.4%) |
Jun 2014 | - | $1700.00(-90.1%) |
Mar 2014 | - | $17.10 K(-52.5%) |
Dec 2013 | $87.00 K(+7.1%) | - |
Dec 2013 | - | $36.00 K(+73.9%) |
Sep 2013 | - | $20.70 K(+69.7%) |
Jun 2013 | - | $12.20 K(-30.7%) |
Mar 2013 | - | $17.60 K(-49.4%) |
Dec 2012 | $81.20 K(-61.4%) | - |
Dec 2012 | - | $34.80 K(+89.1%) |
Sep 2012 | - | $18.40 K(+187.5%) |
Jun 2012 | - | $6400.00(-70.6%) |
Mar 2012 | - | $21.80 K(-51.3%) |
Dec 2011 | $210.10 K(-17.1%) | - |
Dec 2011 | - | $44.80 K(-30.7%) |
Sep 2011 | - | $64.60 K(+2.7%) |
Jun 2011 | - | $62.90 K(>+9900.0%) |
Mar 2011 | - | $500.00(-99.5%) |
Dec 2010 | $253.50 K | - |
Dec 2010 | - | $97.00 K(+99.2%) |
Sep 2010 | - | $48.70 K(+6857.1%) |
Jun 2010 | - | $700.00(-98.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $59.90 K(-38.8%) |
Dec 2009 | $236.50 K(-36.2%) | - |
Dec 2009 | - | $97.80 K(+98.0%) |
Sep 2009 | - | $49.40 K(+25.1%) |
Jun 2009 | - | $39.50 K(-24.5%) |
Mar 2009 | - | $52.30 K(-68.2%) |
Dec 2008 | $370.70 K(-35.6%) | - |
Dec 2008 | - | $164.50 K(+183.1%) |
Sep 2008 | - | $58.10 K(-17.7%) |
Jun 2008 | - | $70.60 K(+14.2%) |
Mar 2008 | - | $61.80 K(-86.6%) |
Dec 2007 | $575.80 K(+175.2%) | - |
Dec 2007 | - | $460.40 K(+946.4%) |
Sep 2007 | - | $44.00 K(-21.6%) |
Jun 2007 | - | $56.10 K(+15.0%) |
Mar 2007 | - | $48.80 K(-154.3%) |
Dec 2006 | $209.20 K(+23.3%) | - |
Dec 2006 | - | -$89.90 K(-358.3%) |
Sep 2006 | - | $34.80 K(-83.9%) |
Jun 2006 | - | $215.90 K(+325.8%) |
Mar 2006 | - | $50.70 K(+13.2%) |
Dec 2005 | $169.70 K(+10.1%) | - |
Dec 2005 | - | $44.80 K(+78.5%) |
Sep 2005 | - | $25.10 K(-36.8%) |
Jun 2005 | - | $39.70 K(-76.3%) |
Mar 2005 | - | $167.70 K(+419.2%) |
Dec 2004 | $154.10 K(-30.2%) | - |
Jun 2004 | - | $32.30 K(-25.1%) |
Mar 2004 | - | $43.10 K(-70.5%) |
Dec 2003 | $220.80 K(+119.7%) | - |
Dec 2003 | - | $146.30 K(+600.0%) |
Sep 2003 | - | $20.90 K(-39.8%) |
Jun 2003 | - | $34.70 K(+35.0%) |
Mar 2003 | - | $25.70 K(+21.8%) |
Dec 2002 | $100.50 K(-19.9%) | - |
Dec 2002 | - | $21.10 K(+2.4%) |
Sep 2002 | - | $20.60 K(-39.6%) |
Jun 2002 | - | $34.10 K(+37.5%) |
Mar 2002 | - | $24.80 K(-4233.3%) |
Dec 2001 | $125.50 K(+25.1%) | - |
Dec 2001 | - | -$600.00(-101.1%) |
Sep 2001 | - | $54.00 K(-25.6%) |
Jun 2001 | - | $72.60 K(+181.4%) |
Mar 2001 | - | $25.80 K(-6.5%) |
Dec 2000 | $100.30 K(-19.0%) | - |
Dec 2000 | - | $27.60 K(+23.2%) |
Sep 2000 | - | $22.40 K(-13.2%) |
Jun 2000 | - | $25.80 K(+6.2%) |
Mar 2000 | - | $24.30 K(-5.8%) |
Dec 1999 | $123.80 K(-20.9%) | - |
Dec 1999 | - | $25.80 K(-0.8%) |
Sep 1999 | - | $26.00 K(-28.6%) |
Jun 1999 | - | $36.40 K(+2.8%) |
Mar 1999 | - | $35.40 K(-23.9%) |
Dec 1998 | $156.50 K(-22.3%) | - |
Dec 1998 | - | $46.50 K(+45.3%) |
Sep 1998 | - | $32.00 K(-25.9%) |
Jun 1998 | - | $43.20 K(+25.6%) |
Mar 1998 | - | $34.40 K(-32.7%) |
Dec 1997 | $201.50 K(+20.4%) | - |
Dec 1997 | - | $51.10 K(+38.1%) |
Sep 1997 | - | $37.00 K(-53.5%) |
Jun 1997 | - | $79.50 K(+138.0%) |
Mar 1997 | - | $33.40 K |
Dec 1996 | $167.30 K | - |
FAQ
- What is ImmunoPrecise Antibodies annual total operating expenses?
- What is the all time high annual operating expenses for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual operating expenses year-on-year change?
- What is ImmunoPrecise Antibodies quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly operating expenses year-on-year change?
What is ImmunoPrecise Antibodies annual total operating expenses?
The current annual operating expenses of IPA is $19.12 M
What is the all time high annual operating expenses for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual total operating expenses is $27.95 M
What is ImmunoPrecise Antibodies annual operating expenses year-on-year change?
Over the past year, IPA annual total operating expenses has changed by -$8.84 M (-31.62%)
What is ImmunoPrecise Antibodies quarterly total operating expenses?
The current quarterly operating expenses of IPA is $4.58 M
What is the all time high quarterly operating expenses for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly total operating expenses is $9.53 M
What is ImmunoPrecise Antibodies quarterly operating expenses year-on-year change?
Over the past year, IPA quarterly total operating expenses has changed by -$516.30 K (-10.13%)